Outcomes of durable versus biodegradable polymer drug-eluting stents in patients with coronary artery disease.

ABSTRACT:

Background

Percutaneous coronary intervention (PCI) is among the most common cardiovascular procedures, but stents still pose risks of restenosis or thrombosis. Drug-eluting stents (DES) with polymer coatings have improved long-term outcomes.

Aim

This study evaluated whether the latest biodegradable polymer DES (BP-DES) offer improved safety over durable polymer DES (DP-DES).

Methods

Data were collected from a single-centre registry at the Medical University of Vienna, including patients who underwent PCI between 2015 and 2020. Patients were categorized by stent type and PCI indication (All Comer, CCS-PCI, ACS-PCI). The primary endpoint comprised of major adverse cardiac events (MACE), including target lesion revascularization (TLR), target vessel revascularization (T

SUBMITTER: Skos C 

PROVIDER: S-EPMC12906131 | biostudies-literature | 2026 Apr

REPOSITORIES: biostudies-literature